- Investors
Scanfil Option Scheme 2022
On 21 April 2022, the Annual General Meeting of Scanfil plc decided to authorize the Board of Directors to decide on granting stock options rights to key personnel of the Scanfil Group and to decide on the terms and conditions of the maximum amount of 1,200,000 option rights.
Based on the authorization, the Board of Directors has on 27 October 2022 decided on general terms and conditions of option plan “Option plan 2022”, and issuing 1,200,000 option rights.
Option rights 2022
In the same context with the issuing, the CEO, the members of the Management Group and other 17 key personnel were distributed in total 316,000 option rights 2022AI and 2022AII of which the CEO Petteri Jokitalo 120,000 pcs, and the members of the Management Group 20,000 pcs each and other 17 key personnel 96,000 pcs in total.
The total amount of the option program is a maximum of 1,200,000 option rights and they are given free of charge. Of these options, 400,000 will be marked with the codes 2022AI and 2022AII, 400,000 2022BI and 2022BII and 400,000 2022CI and 2022CII. The options entitle the holder to subscribe for a maximum of 1,200,000 of the company’s new or existing shares.
The subscription period for option right 2022AI and 2022AII is 1 May 2025 – 30 April 2027, for option right 2022BI and 2022BII 1 May 2026 – 30 April 2028, and for option right 2022CI and 2022CII 1 May 2027 – 30 April 2029. The total number of option rights can be 1,200,000 and they entitle the key personnel to subscribe for a combined total of 1,200,000 of the company’s new shares or shares in company’s possession.
The share subscription price for 2022AI and 2022AII are the Company’s trading volume weighted by the Company’s average share price on the Nasdaq Helsinki 1 November 2022 – 30 November 2022, for option rights 2022BI and 2022BII the trading volume weighted by the Company’s average share price on the Nasdaq Helsinki 1 November 2023 – 30 November 2023, and for 2022CI and 2022CII the trading volume weighted by the Company’s average share price on the Nasdaq Helsinki 1 November 2024 – 30 November 2024. The share subscription price is entered in the Company’s reserve for invested non-restricted equity.
Scanfil Option Scheme 2019
On 24 April 2019, the General Meeting of shareholders of Scanfil Plc decided to authorize the Board of Directors to decide on granting stock options rights to certain key personnel of the company and its subsidiaries. The total number of option rights can be 900,000 and they entitle the key personnel to subscribe for a combined total of 900,000 of the company’s new shares or shares in the company’s possession.
Option rights 2019A
Based on the authorization by the General Meeting, the Board of Directors has on 27 November 2019 decided to grant the CEO and members of the Management Group option rights in all for 210,000 shares as follows: Petteri Jokitalo 110,000 pcs, Riku Hynninen 20,000 pcs, Kai Valo 20,000 pcs, Timo Sonninen 20,000 pcs, Markku Kosunen 20,000 pcs and Kristoffer Asklöv 20,000. The option rights shall be marked “2019A”. Each option right entitles its holder to subscribe for one (1) of the company’s new shares or shares in its possession. The subscription period for option right 2019A is 1 May 2022 – 30 April 2024. The subscription period for the option rights included in the option plan will not begin, unless the production and financial goals and conditions, set separately by the Board of Directors for exercising the option rights, are met. The option rights whose goals are not met will expire as determined by the Board. The stock options were granted without compensation. The subscription price of option right 2019A is EUR 4.04 which is the trading-volume weighted average share price in the NASDAQ OMX Helsinki of the period 1 – 31 March 2019
Option rights 2019B
Based on the authorization by the General Meeting, the Board of Directors has on 27 October 2020 decided to grant the CEO and members of the Management Group option rights in all for 220,000 shares as follows: Petteri Jokitalo 120,000 pcs, Riku Hynninen 20,000 pcs, Kai Valo 20,000 pcs, Timo Sonninen 20,000 pcs, Markku Kosunen 20,000 pcs and Kristoffer Asklöv 20,000. The option rights shall be marked “2019B”. Each option right entitles its holder to subscribe for one (1) of the company’s new shares or shares in its possession. The subscription period for option right 2019B is 1 May 2023 – 30 April 2025. The subscription period for the option rights included in the option plan will not begin, unless the production and financial goals and conditions, set separately by the Board of Directors for exercising the option rights, are met. The option rights whose goals are not met will expire as determined by the Board. The stock options were granted without compensation. The subscription price of option right 2019B is EUR 4.34 which is the trading-volume weighted average share price in the NASDAQ OMX Helsinki of the period 1 – 31 March 2020
Option rights 2019C
Based on the authorization by the General Meeting, the Board of Directors has on 25 November 2021 decided to grant the CEO and members of the Management Group option rights in all for 200,000 shares as follows: Petteri Jokitalo 120,000 pcs, Riku Hynninen 20,000 pcs, Kai Valo 20,000 pcs, Timo Sonninen 20,000 pcs and Markku Kosunen 20,000 pcs. The option rights shall be marked “2019C”. Each option right entitles its holder to subscribe for one (1) of the company’s new shares or shares in its possession. The subscription period for option right 2019C is 1 May 2024 – 30 April 2026. The subscription period for the option rights included in the option plan will not begin, unless the production and financial goals and conditions, set separately by the Board of Directors for exercising the option rights, are met. The option rights whose goals are not met will expire as determined by the Board. The stock options were granted free of charge. The subscription price of option right 2019C is EUR 7.37 which is the trading-volume weighted average share price in the Nasdaq Helsinki of the period 1 – 31 March 2021.